CRMDCorMedix Inc.

Nasdaq cormedix.com


$ 5.88 $ 0.05 (0.86 %)    

Monday, 06-May-2024 15:59:53 EDT
QQQ $ 439.97 $ 4.77 (1.1 %)
DIA $ 388.40 $ 1.68 (0.43 %)
SPY $ 516.34 $ 5.28 (1.03 %)
TLT $ 90.16 $ 0.35 (0.39 %)
GLD $ 215.21 $ 2.24 (1.05 %)
$ 5.89
$ 5.90
$ 0.00 x 0
$ 0.00 x 0
$ 5.84 - $ 6.04
$ 2.57 - $ 7.00
748,073
na
323.84M
$ 1.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-12-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-29-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-16-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 03-14-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-19-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-16-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 03-15-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-06-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-12-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jmp-securities-reiterates-market-outperform-on-cormedix-maintains-19-price-target

JMP Securities analyst Jason Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $19 price target.

 needham-reiterates-buy-on-cormedix-maintains-10-price-target

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

 cormedix-inc-announces-5-year-contract-with-dialysis-provider-arc-dialysis-for-the-supply-of-defencath

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseas...

 rbc-capital-maintains-outperform-on-cormedix-lowers-price-target-to-9

RBC Capital analyst Gregory Renza maintains Cormedix (NASDAQ:CRMD) with a Outperform and lowers the price target from $10 to...

 needham-maintains-buy-on-cormedix-maintains-10-price-target

Needham analyst Serge Belanger maintains Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

 cormedix-q4-gaap-eps-026-misses-020-estimate-cash-and-short-term-investments-of-76m

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.20) by...

 earnings-scheduled-for-march-12-2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

 cormedix-earnings-preview
Cormedix Earnings Preview
03/11/2024 18:01:18

 truist-securities-maintains-buy-on-cormedix-lowers-price-target-to-14-report-released-on-30-january-2024

Truist Securities analyst Joon Lee maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from $18 to $14.

 cormedix-inc-announces-commercial-and-operational-updates-related-to-its-business-and-anticipated-launch-of-defencath

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

 cormedix-inc-announces-partnership-with-the-leapfrog-group

– CorMedix to advocate for patient safety and infection prevention as part of Leapfrog's Partners Advisory CommitteeBERKELE...

 why-cormedix-stock-popped-wednesday

CorMedix Inc. (NASDAQ: CRMD) shares traded higher Wednesday after the company reported better-than-expected third-quarter earni...

 why-shapeways-holdings-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

 needham-maintains-buy-on-cormedix-lowers-price-target-to-10

Needham analyst Serge Belanger maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from $12 to $10.

 rbc-capital-maintains-outperform-on-cormedix-raises-price-target-to-10

RBC Capital analyst Gregory Renza maintains Cormedix (NASDAQ:CRMD) with a Outperform and raises the price target from $6 to ...

 truist-securities-reiterates-buy-on-cormedix-maintains-18-price-target

Truist Securities analyst Joon Lee reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $18 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION